Amn Healthcare Services Inc. (AMN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Amn Healthcare Services’s revenue went from $1.9B in fiscal 2016 to $2.7B in fiscal 2025, growth of about 4.1% a year.
Net income in fiscal 2025 was -$96M, a net margin of -3.5%; the best year in this period was 2022 with $444M.
Over the twelve months to September 30, 2026, revenue was $3.5B and net income $109M.
Free cash flow was $234M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 22% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5B | $2.7B | $3.0B | $3.8B | $5.2B | $4.0B | $2.4B | $2.2B | $2.1B | $2.0B | $1.9B |
| Gross profit | $999M | $774M | $919M | $1.2B | $1.7B | $1.3B | $792M | $743M | $696M | $644M | $620M |
| Operating income | $203M | -$55M | -$103M | $338M | $647M | $478M | $149M | $177M | $203M | $212M | $192M |
| Net income | $109M | -$96M | -$147M | $211M | $444M | $327M | $71M | $114M | $142M | $133M | $106M |
| EPS (diluted) | $2.76 | $-2.48 | $-3.85 | $5.36 | $9.90 | $6.81 | $1.48 | $2.40 | $2.91 | $2.68 | $2.15 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | −8.5% | −21.3% | −27.7% | +31.6% | +66.5% | +7.7% | +4.0% | +7.4% | +4.5% | +30.0% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $361M | $269M | $320M | $372M | $654M | $305M | $257M | $225M | $227M | $161M | $134M |
| Capital spending | -$34M | -$36M | -$81M | -$104M | -$76M | -$54M | -$38M | -$35M | -$35M | -$27M | -$22M |
| Free cash flow | $327M | $234M | $240M | $268M | $578M | $252M | $219M | $190M | $192M | $134M | $112M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $11M | $0 | $0 | $425M | $577M | $3M | $0 | $19M | $67M | $20M | $13M |
| Stock-based pay | $34M | $31M | $23M | $18M | $30M | $25M | $20M | $16M | $11M | $10M | $11M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $34M | $11M | $33M | $65M | $181M | $29M | $83M | $14M | $15M | $11M |
| Debt | — | $803M | $1.1B | $1.4B | $861M | $867M | $955M | $722M | $555M | $320M | $363M |
| Equity | — | $642M | $707M | $831M | $1.0B | $1.2B | $820M | $737M | $639M | $563M | $449M |
| Total assets | — | $2.1B | $2.4B | $2.9B | $2.9B | $3.1B | $2.4B | $1.9B | $1.5B | $1.3B | $1.2B |
| Shares (diluted) | 40M | 39M | 38M | 39M | 45M | 48M | 48M | 48M | 49M | 49M | 49M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 28.4% | 28.3% | 30.8% | 33.0% | 32.7% | 32.9% | 33.1% | 33.5% | 32.6% | 32.4% | 32.6% |
| Operating margin | 5.8% | -2.0% | -3.4% | 8.9% | 12.3% | 12.0% | 6.2% | 8.0% | 9.5% | 10.7% | 10.1% |
| Net margin | 3.1% | -3.5% | -4.9% | 5.6% | 8.5% | 8.2% | 2.9% | 5.1% | 6.6% | 6.7% | 5.6% |
| FCF margin | 9.3% | 8.6% | 8.0% | 7.1% | 11.0% | 6.3% | 9.2% | 8.5% | 9.0% | 6.7% | 5.9% |
| ROIC | — | -3.6% | -4.9% | 11.5% | 24.9% | 17.4% | 6.5% | 9.3% | 12.9% | 16.6% | 14.2% |
| ROE | — | -14.9% | -20.8% | 25.3% | 42.5% | 28.2% | 8.6% | 15.5% | 22.2% | 23.6% | 23.5% |
Frequently asked questions
What is Amn Healthcare Services’s annual revenue?
$2.7B in fiscal 2025 and $3.5B over the twelve months to September 30, 2026.
How much profit does Amn Healthcare Services make?
Net income was -$96M in fiscal 2025 (net margin -3.5%).
Is Amn Healthcare Services’s revenue growing?
No: revenue fell 8.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.